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ABSTRACT 
BACKGROUND:  The ideal postoperative analgesia management of elderly surgical 
patients in intensive care units (ICUs) is continually being investigated. 
OBJECTIVE: The purpose of this study was to assess the effectiveness and toler- 
ability of IV administration of dexmedetomidine as an adjunct to a low-dose epidural 
bupivacaine infusion for postoperative analgesia fter abdominal surgery in elderly 
patients in the ICU. 
METHODS: ICU patients aged >70 years undergoing abdominal surgery were 
eligible for the study. A lumbar epidural catheter was inserted at the beginning of the 
surgery with no medication. On arrival at the ICU, the catheter was loaded with 0.25% 
bupivacaine 25 mg at the T8 to T10 sensory level, and a continuous infusion of 0.125% 
bupivacaine was started at 4 to 6 mL/h in combination with patient-controlled pidural 
analgesia (PCEA) of fentanyl (4 pg/bolus) for pain treatment. Patients in the treatment 
group received exmedetomidine as an IV loading dose of 0.6 pg/kg for 30 minutes 
followed by continuous infusion at 0.2 gg/kg • h 1. Patients in the control group were 
not administered dexmedetomidine. The effectiveness of the pain relief was determined 
using a visual analog scale (VAS) (0 no pain to 10 worst pain imaginable) at rest. 
VAS score, heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure, and 
arterial blood gases were monitored periodically for 24 hours after surgery. I f  required, 
tenoxicam (20-mg IV bolus) was used to ensure a VAS score of <3. The number of times 
PCEA and tenoxicam were administered and the occurrence of adverse vents (AEs) 
were also recorded. 
RESULTS:  Sixty patients (34 men, 26 women; mean [SD] age, 75.96 [4.25] years; 
mean [SD] weight, 74.13 [10.62] kg) were included in the study. VAS scores were signifi- 
cantly lower in the dexmedetomidine group compared with the control group at hours 
1, 2, and 12 (VAS [hour 1]: 2.8 [0.4], P < 0.001; VAS [hour 2]: 2.7 [0.5], P < 0.001; and 
VAS [hour 12]: 0.9 [0.7], P 0.044). The mean number of administrations of fentanyl 
via PCEA was significantly greater in the control group compared with the dexmedeto- 
midine group (2.20 vs 6.63 times; P < 0.001). The mean number of administrations of
tenoxicam was significantly lower in the treatment group than the control group (0.27 
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vs 1.07 times; P < 0.001). In the control group, the decreases in sedation at 0, 8, 12, 16, 
and 20 hours were significant compared with baseline (P 0.024, P 0.001, P 0.020, 
P < 0.001, and P 0.005, respectively). Mean HR, SBR and AEs (eg, bradycardia [HR 
<60 beats/mini, respiratory depression [respiratory rate <8 breaths/mini, hypotension 
[SBP <90 mm Hg], oversedation, hypoxia, and hypercapnia) decreased significantly in 
the dexmedetomidine group (all, P < 0.05). Significantly more patients in the dexmede- 
tomidine group rated their satisfaction with postoperative pain control as excellent 
compared with the control group (12 vs 6 patients; P 0.014). 
CONCLUSION"  Intravenous dexmedetomidine was e**ective and generally well 
tolerated as an analgesic adjunct to epidural ow-dose bupivacaine infusion for pain 
treatment, with lower need for opioids after abdominal surgery in these elderly intensive 
care patients than in the control group. (Curt Ther Res Clin Exp. 2008;69:1628) ©2008 
Excerpta Medica Inc. 
K~'Y WORDS" postoperative analgesia, elderly patients, dexmedetomidine, epidural 
analgesia. 
INTRODUCTION 
Elderly surgical patients in intensive care units (ICUs) manifest specific characteristics, 
including cardiac conditions, systemic pathologies, and increased sensitivities to seda- 
tives and analgesics, that require additional attention when choosing the appropriate 
analgesic routes of administration a d drugs) 3 
Epidural analgesia is the most commonly recommended method for postoperative 
pain management of this age group) However, choosing the optimal epidural drug is 
still the subject of many investigations. 2,4Using only local anesthetics ateftective doses 
raises concerns about adverse vents (AEs), such as hypotension, bradycardia, motor 
weakness, and elevation in block level. 30pioid combinations may not provide satisfac- 
tory results, as they are associated with respiratory failure, nausea, and vomiting. 2,3 
Because of its eftective sedative properties, use of the ot2-agonist dexmedetomidine 
in intensive care patients is under study. 54 Its use in pain management has also been 
studied because of its analgesic attributes. 8 11 However, as with other Ot2-agonists, the 
AEs associated with dexmedetomidine (eg, bradycardia, hypotension), which are caused 
by its central sympatholytic eftects, are still being investigated. 7,12 
The aim of this study was to investigate the eftectiveness and tolerability of the 
analgesia obtained by combining a low-dose local anesthetic n epidural analgesia with 
IV dexmedetomidine i fusion for postoperative pain management of elderly surgical 
intensive care patients. 
PAT IENTS AND METHODS 
The ethics committee of Baskent University School of Medicine, Adana, Turkey, 
approved the study, which was designed as a prospective clinical investigation with 
patients aged >70 years who were to undergo major abdominal surgery and to be moni- 
tored postoperatively in the ICU of the university. Patients with advanced heart failure 
(ejection fraction <30%); respiratory failure; indications for mechanical ventilation; a
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diagnosis of kidney or liver failure; use of long-term narcotic drugs for any reason; or 
a history of vertebral surgery, coagulation defect, bleeding diathesis, sepsis, shock, or a 
neurologic pathology similar to dementia that might hamper their ability to cooperate 
were excluded from the study. Written informed consent was obtained from all partici- 
pants prior to study enrollment. 
Anesthesia was induced using IV thiopental sodium 5 mg/kg and fentanyl 1 lag/kg; 
IV vecuronium 0.1 mg/kg was administered for muscle relaxation. After endotracheal 
intubation, anesthesia was to be maintained using 1% isoflurane and nitrous oxide in 
50% oxygen. The patient was placed in the left lateral position, and an 18-gauge pi- 
dural catheter (Portex ® Epidural Minipack, Smiths Medical, Hythe, United Kingdom) 
was inserted into the L3 to L4 intervertebral space. Surgery was performed without 
sending any medication or saline through the catheter. 
After surgery, patients were extubated and transferred to the ICU. No vasoactive 
drug was administered to the patients. Fluid was administered to maintain central 
venous pressure at 7 to 9 mm Hg and hematocrit >30%. After the initial administra- 
tion of 0.25% plain bupivacaine 25 mg (AstraZeneca LP, Wilmington, Delaware) epi- 
durally as the loading dose, 0.125% plain bupivacaine was started at an infusion rate of 
4 to 6 mL/h to achieve analgesia t the T8 to T10 sensory level. 
The study was designed as a pseudorandomized clinical trial. After achieving ade- 
quate analgesia, the patients were divided into 2 groups based on the order in which 
they were admitted to the ICU. The patients and the investigators assessing responses 
and AEs were blinded to treatment allocation. Dexmedetomidine* was administered to
the treatment group at an infusion rate of 0.6 lag/kg for 30 minutes and maintained at 
0.2 lag/kg • h 1. The control group was not administered dexmedetomidine. 
A visual analog scale (VAS) (0 no pain to 10 worst pain imaginable) was used to 
assess pain intensity and a sedation-agitation scale (SAS) (1 unarousable to 7 dan- 
gerous agitation) was used to assess edation level. 13 Analgesia was planned to assure a 
VAS score <3 in both groups. The analgesia level could be increased when required (ie, 
VAS score >3 after 30 minutes of analgesia) using patient-controlled pidural analgesia 
(PCEA) with fentanyl 2-mL/bolus (2 lag/mL) and a lockout ime of 10 minutes. In addi- 
tion, tenoxicam (20-mg IV bolus) could be administered, if required (ie, VAS score >3 
after 30 minutes of epidural fentanyl administration). 
Analgesia level, hemodynamic parameters (heart rate [HR], systolic blood pressure 
[SBP], and diastolic blood pressure [DBP]), arterial blood gases, peripheral oxygen satu- 
ration, and sedation level at 0, 0.5, 1, 2, 4, 8, 12, 16, 20, and 24 hours were recorded 
for all study patients. Hemodynamic parameters, blood gas analysis, and respiratory 
function were used to assess the effectiveness and tolerability of pain treatment. AEs (eg, 
bradycardia [HR <60 beats/mini, respiratory depression [respiratory rate <8 breaths/ 
mini, hypotension [SBP <90 mm Hg], oversedation, hypoxia, and hypercapnia) were 
assessed throughout the study. The number of PCEA administrations of fentanyl and 
the number of tenoxicam doses were determined at the end of the 24-hour postsurgi- 
cal period. The patients were also asked if they experienced any AEs, and they were 
*Trademark: Precedex ® (Hospira Inc., Lake Forest, Illinois). 
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specifically asked about nausea and vomiting, pruritus, or unexpected headache (all 
epidural catheters were inserted very carefully to prevent spinal headache). At the end 
of the study, patient satisfaction with postoperative pain control was investigated using 
a validated scale (1 bad, 2 moderate, 3 good, 4 excellent). 14
STAT IST ICAL  ANALYS IS  
Statistical analysis was performed using the Statistical Package for Social Sciences, 
version 11.0 (SPSS Inc., Chicago, Illinois). The Student  test and paired t test were used 
to analyze normally distributed ata. Data that were not normally distributed were 
assessed using the Mann-Whitney U test and Wilcoxon signed-rank test. P < 0.05 
was considered to be statistically significant. A sample size of 22 patients per group 
was determined, through power analysis (o~ 0.05; ~ 0.90), to be needed to detect a 
decrease in VAS score to three 1 hour postoperatively with an SD of 1. Thirty patients 
were enrolled per group to account for dropouts. 
RESULTS 
Sixty patients (34 men, 26 women; mean [SD] age, 75.96 [4.25] years; mean [SD] 
weight, 74.13 [10.62] kg) were included in the study. No significant differences were found 
between the groups in age, sex, weight, height, or duration or type of surgery (Table). 
During the course of the study, hemodynamic parameters (HR, SBP, DBP) in the 
dexmedetomidine and control groups decreased significantly compared with baseline 
values (all, P < 0.05) (Figure 1). While the mean HR in the treatment group was 
significantly lower at hour 2 compared with the control group (86.43 [5.26] vs 93.03 
Table. Baseline demographic and clinical characteristics of elderly intensive care 
patients requiring abdominal surgery (N = 60).* 
Dexmedetomidine Control 
Group Group 
Variable (n = 30) (n = 30) 
Age, mean (SD), y 75.66 (3.86) 76.26 (4.66) 
Sex, no. (%) 
Male 16 (53.3) 18 (60.0) 
Female 14 (46.7) 12 (40.0) 
Weight, mean (SD), kg 73.43 (9.98) 74.83 (11.35) 
Height, mean (SD), cm 167.03 (8.45) 158.80 (23.82) 
Duration of surgery, mean (SD), min 269.33 (78.86) 269.00 (89.03) 
Type of surgery, no. 
Whipple surgery 7 7 
Total or hemicolectomy 11 9 
Intestinal resection 8 9 
Radical cystectomy 4 5 
*No significant between-group differences were found. 
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Figure 1. Hemodynamic parameters (heart rate [HR] in beats per minute, systolic blood 
pressure [SBP] in mm Hg, diastolic blood pressure [DBP] in mm Hg) and 
peripheral oxygen saturation (Sp02) in mm Hg by treatment group in elderly 
intensive care patients requiring abdominal surgery (N = 60). *P < 0.001 versus 
control. 
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[9.49] beats/min; P < 0.001), there were no other significant between-group differences 
in HR. Whereas the decrease in HR in the treatment group was significantly lower 
than in the control group, after 16 hours none of the HR values were found to be out- 
side the normal range (16-hour mean HR of treatment group: 73.63 [4.27] beats/min). 
Although SBP values were within the normal range, they were found to be decreased 
significantly in the treatment group beginning with hour 1 compared with baseline. 
SBP values were significantly decreased throughout the 24-hour period (all, P < 0.001). 
Except at hour 1 in the treatment group (79.86 [6.62]; P 0.007), there were no signifi- 
cant between-group differences in DBR No significant differences were found in blood 
gas analysis or peripheral oxygen saturation between groups. 
After 1 hour, VAS scores indicated that analgesia was effective in both groups com- 
pared with baseline values. VAS scores were significantly lower in the dexmedetomidine 
group compared with the control group at hours 1, 2, and 12 (VAS [hour 1]: 2.8 [0.4], 
P < 0.001; VAS [hour 2]: 2.7 [0.5], P < 0.001; and VAS [hour 12]: 0.9 [0.7], P 0.044) 
(Figure 2). 
The mean number of administrations of fentanyl via PCEA was significantly greater 
in the control group compared with the dexmedetomidine group (2.20 vs 6.63 times; 
P < 0.001) (Figure 3). The mean number of administrations of tenoxicam was also sig- 
nificantly lower in the dexmedetomidine group than in the control group (0.27 vs 
1.07 times; P < 0.001). 
SAS scores decreased in both groups compared with baseline values. In the con- 
trol group, the decreases at 0, 8, 12, 16, and 20 hours were significant (SAS [hour 0]: 
5.1 [1.0], P 0.024; SAS [hour 8]: 2.4 [0.5], P 0.001; SAS [hour 12]: 3.2 [0.6], P 
0.020; SAS [hour 16]: 3.1 [0.3], P < 0.001; and SAS [hour 20]: 3.3 [0.4], P 0.005) 
(Figure 4). 
In the control group, 5 patients (16.7%) were administered atropine sulfate (0.5 mg 
IV) for the treatment of bradycardia and 4 patients (13.3%) required volume replace- 
ment due to hypotension. Five patients (16.7%) in the control group and 1 patient 
(3.3%) in the dexmedetomidine group had postoperative nausea. No other AEs were 
experienced in the treatment group. 
Significantly more patients in the dexmedetomidine group compared with the con- 
trol group rated their satisfaction with postoperative pain control to be excellent (12 vs 
6 patients; P 0.014) (Figure 5). In both groups, 18 patients rated the experience as 
good. Six patients in the control group compared with none in the treatment group 
were not adequately satisfied with postoperative pain control. 
DISCUSSION 
The number of surgeries performed in elderly patients has been increasing rapidly) 
Particularly after major surgeries, such as intra-abdominal surgery, these patients are 
closely monitored in the ICU with hemodynamic and respiratory follow-up, bleeding 
control, and effective postoperative analgesia nd sedation. 2 
Appropriate sedation and analgesia levels during the postoperative p riod in geriatric 
patients are known to significantly affect morbidity and mortality by decreasing delir- 
ium and preventing age-related pharmacodynamic and pharmacokinetic changes) :5 
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Figure 2. Visual analog scale (VAS) scores for pain level by treatment group in elderly 
intensive care patients requiring abdominal surgery (N = 60).  Scale: 0 = no 
pain to 10  = worst pain imaginable. *P < 0 .001  versus control; tp  = 0 .044  
versus control. 
The importance of pain management in postoperative delirium, which is seen com- 
monly in elderly patients, is a significant factor in delaying recovery. 9,15 18 While the 
analgesia plan to be used during the postoperative p riod varies depending on the age 
of the patient, the type of surgery, and the overall health status of the patient, ideal 
methods and drugs to be used for analgesia re still under investigation. Physiologic and 
systemic pathologic hanges occurring in elderly patients contribute to the importance 
of the postoperative analgesia method. 1,2 
Epidural techniques are commonly used in postoperative analgesia for elderly 
patients, with the combination of a local anesthetic and an opioid being preferred. 3,4 
However, the occurrence of serious AEs (eg, hypotension, respiratory depression, deep 
bradycardia) nd unwanted AEs (eg, nausea, vomiting, motor block) with these analge- 
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Figure 3. Mean number of doses of epidural fentanyl and IV tenoxicam by treatment group in 
elderly intensive care patients requiring abdominal surgery (N = 60). *P < 0.001.  
sic regimens make it necessary to continue research about different and more optimal 
analgesia methods. 1,3 The 0~2-agonists , particularly the combination of clonidine with 
local anesthetics administered via the epidural or spinal route, has been found to be 
effective in pain management. 19 21 Dexmedetomidine, another o~2-receptor agonist, is 
commonly used in ICUs for sedation of patients with psychological problems, including 
delirium. <7,22 The dose range of this drug, preferably used intravenously, varies depend- 
ing on the severity of the sedation (SAS <3; difficult to arouse but awakens to verbal 
stimuli and drifts off again). 23 In various clinical studies, dexmedetomidine has been 
found to reduce the doses of opioids, benzodiazepines, propofol, and antipsychotic drugs 
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Figure 4. Mean sedation-agitation scale scores by treatment group in elderly intensive 
care patients requiring abdominal surgery (N = 60). Scale: 1 = unarousable to 
7 = dangerous agitation. *P  = 0 .024  versus control; tp = 0.001;  ~P = 0.020;  
§P < 0.001;  lip = 0 .005.  
in ICUs. 6,v The effective analgesia obtained with dexmedetomidine has been widely 
discussed.8 11 Its effect on increasing sedation and analgesia via its central influence 
on the locus ceruleus and the posterior horn of the spinal cord has been reported. 24 
However, clinical studies on its spinal and epidural use are limited. 
The aim of this study was to determine the effectiveness and tolerability of a moder- 
ate dose of IV dexmedetomidine on postoperative pain relief combined with a continu- 
ous low-dose local anesthetic administered epidurally. Because sedation and hemody- 
namic AEs associated with dexmedetomidine may be a problem for geriatric patients, >
the drug was used in moderate doses. The required analgesic dose for all the patients 
was supported by low-level epidural fentanyl administration at intervals via PCEA. In 
cases where the epidural technique was insufficient, intravenous tenoxicam was added 
to the treatment. 
During the study we used a VAS to assess the effectiveness of pain relief; maintain- 
ing a VAS score <3 was the main goal of the study. In the present study, adequate 
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Figure 5. Patient satisfaction scale scores for postoperative pain control by treatment 
group in elderly intensive care patients requiring abdominal surgery (N = 60).  
Scale: 1 = bad, 2 = moderate, 3 = good, 4 = excellent. *P  < 0 .014  versus 
control. 
analgesia levels were achieved in both groups. However, the fact that although VAS val- 
ues in the dexmedetomidine group were significantly lower than in the control group at 
some measurement times, the need for a significantly lower number of doses of fentanyl 
may be an important advantage. This result supports the systemic analgesic attribute of 
dexmedetomidine.8 11,25 Therefore, a lower number of doses of fentanyl and tenoxicam 
may be associated with fewer AEs and lower sedation, which may contribute to more a 
comfortable postoperative p riod for patients. 
Dexmedetomidine was reported to increase the sedative ffects of opioids but was as 
effective as opioids when used as monotherapy. 8'26 In this study, a more continuous and 
moderate sedation level was observed in the dexmedetomidine group. However, while 
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the sedation level in the control group was different from baseline and compared with the 
treatment group at most times, occasional occurrences ofdeep sedation were thought o 
be associated with the frequency of the fentanyl boluses. Administering dexmedetomidine 
via infusion for sedation of ICU patients is particularly recommended to achieve good 
continuous sedation. > In this study, use of dexmedetomidine fusion at a moderate dose 
(0.2 p/kg • h 1) in patients administered a low dose of local anesthetic (0.125% bupiva- 
caine 4 6 mL/h) via epidural catheter was found to be effective. 
While local anesthetics administered epidurally are associated with AEs (eg, respira- 
tory and cardiac events), O~2-agonists are also associated with AEs, such as bradycardia 
and hypotension. 3,7,12 The advantage of a minimal risk for respiratory depression with 
IV dexmedetomidine i  patients with bradycardia and hypotension has been reported 
in studies on ICU sedation. 12,26 In the present study, while mean HR and SBP were 
significantly lower in the dexmedetomidine group, they remained within normal im- 
its which was an advantage in these geriatric patients. This may be associated with 
appropriate analgesia nd sedation levels in the dexmedetomidine group and minimal 
cardiovascular AEs of the drug. 7,8,1°,27 In addition, a significant reduction of nausea nd 
vomiting in the dexmedetomidine-treated patients may have been associated with the 
lower amount of fentanyl they used. 
Although paracetamol and NSAIDs are known to be well tolerated, they are not 
sufficient for pain management after major abdominal surgery. 1,28 In the present study, 
the NSAID tenoxicam was added to the pain management regimen if needed to achieve 
sufficient and safe analgesia. 2 However, a significantly lower requirement for tenoxicam 
in the dexmedetomidine group was found and was one of the advantages ofdexmedeto- 
midine as a coanalgesic n elderly patients. 1°,11 
Patient satisfaction with postoperative pain control was found to be significantly 
higher in the dexmedetomidine group, in which effective analgesia nd sedation were 
achieved with minimal AEs compared with the control group. 
This study was designed as a pseudorandomized clinical trial in which the study 
patients and the investigator assessing the study parameters were blinded to the drugs 
being used. The limitations of this method might be selection bias. Other limitations 
include the small sample size of the study. 
CONCLUSIONS 
In both groups of elderly patients undergoing abdominal surgery, adequate and effective 
pain treatment with hemodynamic stability was provided by IV dexmedetomidine i  
addition to epidural fentanyl. The combination of an epidural ow-dose local anesthetic 
administered with moderate doses of IV dexmedetomidine was effective and was associ- 
ated with significantly lower opioid use and greater patient satisfaction. 
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